Part of the expanding PassProfessor catalog: This program is built — 1,500 original practice questions, weighted to NABP’s current MPJE Competency Statements — and it opens for enrollment soon as part of the expanding PassProfessor catalog. Join the notify list and we will email you when enrollment opens.
This program is part of the expanding PassProfessor catalog — join the notify list and we’ll email you when enrollment opens.
The Delaware MPJE is NABP’s Multistate Pharmacy Jurisprudence Examination as administered for Delaware pharmacist licensure: 120 questions in 2.5 hours at Pearson VUE — 100 scored plus 20 unscored pretest — mixing federal and Delaware law with no distinction between them, reported pass/fail. PassProfessor’s Delaware MPJE program, part of the expanding PassProfessor catalog, holds 1,500 original practice questions — an 800-question federal core intermixed with 700 Delaware questions — weighted to NABP’s current Competency Statements, priced at $49, and opening for enrollment soon.
What is included in the Delaware MPJE program?
A bank built the way the exam is built. The MPJE makes no distinction between federal and state questions, so neither does this bank: 800 federal-core questions and 700 Delaware questions are intermixed in a single 1,500-question bank, and where a Delaware rule differs from the federal rule, the Delaware rule keys the answer — the same instruction NABP gives on the exam itself.
An explanation on every question. Every one of the 1,500 questions carries an explanation of why the keyed answer is right. Jurisprudence is a subject where the tempting wrong answer is usually the other jurisdiction’s rule or the federal default, and the explanation names the distinction instead of leaving you to guess at it.
Practice exams at the real exam’s shape. A full practice exam draws 100 scored questions — the scored length of the real exam — across the four competency areas at their published weights, inside the real 150-minute clock. Draws are generated fresh for each attempt, questions you have not seen come first, and you never sit the same generated exam twice. Practice exams are scored against a 70% practice benchmark — a preparation target only, because the real MPJE reports pass/fail and NABP publishes no raw passing score.
Drills by competency area. Work one area at a time — Licensure and Personnel, Pharmacist Practice, Dispensing Requirements, or Pharmacy Operations — and your results break down by area, so a weak area shows up in your practice data before it shows up on a score report.
The real exam at a glance
Current as of November 2026, per NABP’s MPJE program pages and Competency Statements and Delaware Board of Pharmacy. Full detail — eligibility, application steps, retakes, test day — is in our Delaware MPJE exam guide.
| Exam fact | Delaware MPJE |
|---|---|
| Questions administered | 120 (100 scored + 20 unscored pretest, mixed in) |
| Time limit | 2.5 hours (150 minutes) |
| Format | Computer-based, multiple choice, at Pearson VUE |
| Federal vs. state questions | Intermixed with no distinction; each question is answered under the prevailing law of Delaware |
| Scoring | Pass/fail. NABP does not publish a raw passing score, and no percentage of correct answers is the passing standard |
| Passing score | No numeric passing score is published for this exam — the result is reported as pass or fail |
| Attempts | Up to 5 per jurisdiction |
| Fees | About $270 per attempt in NABP fees |
| Eligibility | Confirmed by the Delaware Board of Pharmacy |
| Score transfer | MPJE scores are not transferable between jurisdictions — a Delaware result applies to Delaware licensure only |
How does the practice map to the real exam?
| NABP competency area | Share of the real exam | Practice questions in this program | Questions per full practice exam |
|---|---|---|---|
| Area 1 — Licensure and Personnel | 22% | 333 | 22 |
| Area 2 — Pharmacist Practice | 33% | 498 | 33 |
| Area 3 — Dispensing Requirements | 24% | 358 | 24 |
| Area 4 — Pharmacy Operations | 21% | 311 | 21 |
The federal half of every MPJE is the same body of law, and it is larger than most candidates expect. The shared 800-question federal core in this program covers the Controlled Substances Act framework end to end: the five schedules, the rule that Schedule II prescriptions never refill, the five-refills-in-six-months limit for Schedules III and IV, emergency oral Schedule II orders and the prescriber’s seven-day follow-up duty, partial fills, pharmacist-to-pharmacist transfers of Schedules III–V, DEA registration and Form 222/CSOS ordering, biennial inventories, theft and loss reporting, and disposal. It covers the Food, Drug, and Cosmetic Act in the form the exam tests it — adulteration versus misbranding, generic substitution and Orange Book equivalence, container labeling, child-resistant packaging, Medication Guides and REMS programs, the three recall classes, expiration and beyond-use dating, DSCSA track-and-trace duties, and the line between 503A patient-specific compounding and 503B outsourcing facilities. It covers OBRA ’90 prospective drug review and counseling duties, USP <795>, <797> and <800> compounding standards, HIPAA’s treatment/payment/operations framework and breach-notification duties, and the personnel principles that hold in every state: the pharmacist-in-charge answers for the pharmacy’s compliance, technicians never counsel, and no dispensing happens when no pharmacist is on duty.
What Delaware law does the exam test?
Half of what makes the Delaware MPJE hard is that it is two bodies of law at once. The Delaware half of this program is built on:
The Delaware questions in this bank are grounded in primary Delaware sources read first-hand: the Pharmacy Act (Title 24 of the Delaware Code, Chapter 25), the Board of Pharmacy regulations (Title 24 of the Delaware Administrative Code, section 2500), the Uniform Controlled Substances Act (Title 16, Chapter 47) and its regulations in Title 24 of the Administrative Code, the prescription monitoring law inside that Act, the generic and biologic substitution law in Chapter 25, the pharmacist contraception law (Title 16, Chapter 30O) and the Opioid Antagonist Access Program law (Title 16, Chapter 30G). Delaware pharmacy law was comprehensively amended effective June 30, 2026, and this bank keys on the amended text — including the discipline law as it now stands.
Delaware’s prescription monitoring program is established inside the Uniform Controlled Substances Act and run by the Office of Controlled Substances; dispensers report Schedule II–V dispensing — and any drug of concern designated by regulation — on the schedule the Office sets by regulation. The check duty is belief-triggered, not universal: a dispenser or prescriber who reasonably believes a patient may be seeking a Schedule II–V substance for a reason other than treatment of an existing medical condition must pull the patient’s utilization report for the preceding 12 months before dispensing or prescribing. Unlawful disclosure of program information is a felony, and a prescriber holding a Delaware controlled-substance registration must register with the program within 90 days of obtaining that registration.
Delaware substitution is permissive and opt-in. A pharmacist may dispense a therapeutically equivalent, lower-priced product only when the prescriber has signed the ‘Substitution Permitted’ line on a written prescription or stated that substitution may be made on a verbal one; the brand product is dispensed when the prescriber handwrites ‘Brand Necessary’ or ‘Brand Medically Necessary,’ and the patient is told whenever a product selection is made. There is no mandatory-substitution rule and no pass-on-the-savings rule. For an interchangeable biologic, the prescriber must be told the product dispensed and its manufacturer within 10 days, unless no interchangeable product exists or the refill is the same product. Delaware also schedules its own way: buprenorphine is Schedule V in Delaware though federal law places it in Schedule III, cannabis remains textually in Schedule I while an adult’s personal-use quantity carries no penalty, and the Secretary may follow a federal scheduling change only when both statutory conditions are met — conformity is never automatic.
The people rules run on even-year cycles: pharmacist licenses and pharmacy permits expire September 30 of even years, with a 60-day late-renewal window, and pharmacists complete 30 hours of continuing education per biennium — including at least 2 hours on medication safety and errors and 2 hours on controlled substances and impairment — with no carryover. Internship is 1,500 hours, at least 1,000 of them in community or hospital practice. Delaware does not license or register pharmacy technicians and sets no numeric pharmacist-to-technician ratio: a technician’s standing rests on national certification and employer training completed within 90 days, and only certified technicians may reconstitute oral solutions, contact prescribers about refill authorization, assist with compounding, or give adult immunizations. Every pharmacy has exactly one pharmacist-in-charge, who serves only that one pharmacy and completes a self-inspection by February 1 each year.
At the counter, three Delaware rules draw questions every cycle: a practitioner dispensing controlled substances to their own patients is capped at a 72-hour supply — pharmacies are expressly excepted; the opioid safe-prescribing limits (a first outpatient opioid for acute pain capped at a 7-day supply, and no opioid for a minor above a 7-day supply) bind prescribers, not pharmacists; and immunizations may be given from age 3 under a prescriber’s order or protocol, with every administration reported to the state registry, DelVAX, within 72 hours. Discipline runs on the current amended text: individual sanctions reach a $10,000 fine for a first violation and $50,000 per subsequent violation, with permanent revocation available — and a pharmacist who dispenses naloxone in good faith under the state’s access program is protected from discipline and liability absent a failure of reasonable care or gross negligence.
What changes on March 1, 2027?
From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline: Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, and Pharmacy Operations 20%. Every question in this bank is dual-tagged to both blueprints, so the program’s practice exams re-weight to the new outline when the change takes effect — the questions you practice stay the right questions, at the new weights. Candidates testing before March 1, 2027 prepare against the current Competency Statements, which is how the bank is weighted today.
How should you use this program?
Work the bank in three passes. First, take a full 100-question practice exam under the 150-minute clock to find your baseline — the per-area results show exactly where the points are being lost. Second, drill the weakest competency area in focused sets, reading the explanation for every item, right or wrong: each explanation states why the keyed answer is right, so a wrong drill answer becomes a rule learned rather than a guess missed. Third, return to full practice exams drawn fresh from the bank — questions you have not seen come first, so a rising score reflects broader coverage rather than memorized items. In the final week, shift the drill mix toward Delaware law: it is the half of the exam that no national review book teaches, and it is where candidates who prepared generically lose the most ground.
What does the program cost?
The Delaware MPJE program is $49 for the full bank — all 1,500 questions, full-length practice exams, and per-area drills. Enrollment opens soon; join the notify list and we will email you when it opens.
Frequently asked questions
How many questions are on the Delaware MPJE?
The exam administers 120 questions in 2.5 hours: 100 scored questions and 20 unscored pretest questions mixed in so they cannot be told apart. Your result rests on the 100 scored questions.
What score do you need to pass the Delaware MPJE?
The MPJE is reported pass/fail against NABP’s passing standard. NABP does not publish a raw passing score, so no percentage — including the 70% benchmark this program uses in practice — is the passing standard. Older guides that quote a numeric scaled threshold describe how the exam used to be reported, not how it is reported now.
Can an MPJE score transfer to another state?
No. MPJE scores are not transferable between jurisdictions. A pass for Delaware supports Delaware licensure only; licensing in another MPJE state means that state’s MPJE as well. (Score transfer belongs to the separate Uniform MPJE used in other jurisdictions.)
How many times can you take the Delaware MPJE?
Up to 5 attempts per jurisdiction. NABP fees run about $270 per attempt, so preparation before the first sitting is the less expensive route.
Who confirms eligibility for the Delaware MPJE?
Eligibility is confirmed by the Delaware Board of Pharmacy. You apply through NABP’s e-Profile, and eligibility must be confirmed before you can schedule at Pearson VUE.
Does the exam separate federal questions from Delaware questions?
No — NABP states that no distinction is made in the examination between federal and state jurisprudence questions, and each question is answered under the prevailing law of Delaware. Where the Delaware rule and the federal rule differ, the Delaware rule decides.
What does this program cover?
1,500 original practice questions: an 800-question federal core (controlled substances, FDA and dispensing law, compounding, privacy, licensure principles) intermixed with 700 questions on Delaware pharmacy law, weighted to NABP’s four competency areas at 22/33/24/21 percent.
Does every question really have an explanation?
Yes — all 1,500 questions in this bank carry an explanation of why the keyed answer is right, verified from the bank files when this page was built.
What happens to my preparation when the blueprint changes in March 2027?
Nothing is lost. Every question is dual-tagged to the current Competency Statements and to the March 1, 2027 Content Outline, and the program re-weights its practice exams to the new outline — 30/30/20/20 — when the change takes effect.
Is this program affiliated with NABP or Delaware Board of Pharmacy?
No. PassProfessor is an independent exam-preparation provider and is not affiliated with NABP, Pearson VUE, or Delaware Board of Pharmacy. The program provides practice questions for preparation; it is not a licensure requirement and confers no eligibility.
When can you enroll?
The program opens for enrollment soon at $49. Join the notify list on this page and we will email you when enrollment opens.
Disclaimer
PassProfessor is an independent exam-preparation provider, based in Salt Lake City, Utah and delivered entirely online. It is not affiliated with NABP, Pearson VUE, or Delaware Board of Pharmacy, and this program is preparation only — it is not pre-licensing education, confers no eligibility, and does not replace the official sources. Exam facts on this page are stated as of November 2026 from NABP and Delaware primary sources; confirm current requirements with NABP and Delaware Board of Pharmacy before you apply.
—